•
Lead and Disrupt
Talks about Innovation, Corporate Innovation and Disruption
SW
Steve Weinstein
Venture Investor
Greater Boston
Overview
Steve Weinstein is a Venture Investor and CEO in the life science industry with notable experience at companies like Novartis and Genentech. He has successfully invested in various companies at different stages, including Syndicate at Seed stage and ROX Medical at Series E, showcasing his expertise in venture capital and strategic planning.
Work Experience
Senior Advisor
2024 - Current
UPMC Enterprises is the innovation, commercialization, and venture capital arm of UPMC.
Innovation Consultant
2024
American Academy of Ophthalmology provides comprehensive and integrated eye care services.
Expert-in-Residence (XIR)
2025
Advise ARPA-H on how to translate their programs from bench to bedside. Advise innovators working on early-stage healthcare technologies.
Strategic Advisor
2019
Clinical research and commercial translation strategy related to mental health, neuomodulation, addiction, and digital tools in clinical practice.
Managing Member
2018
Consultant and Advisor to Venture Funds, Venture Funded Start-ups & Academic Medical Centers
Product Development Review Council Member
2018
Council reviews oncology-focused grants of up to $20M/company.
Cancer Prevention and Research Institute of Texas is a state agency that invests in cancer prevention and academic research.
Raised $2,000,000.00.
Board Member
2021
CEO
2021 - 2023
• Joined as Independent Director. Became Interim CEO to build senior leadership team including CSO, CMO, and Data Science. Developed new R&D and clinical strategy. • Development stage prostate cancer prognostic for monitoring patients with low risk tumors.
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate cancer.
Raised $6,885,377.00 from First Round Capital and Green Park & Golf Ventures.
Board Member
2021
Developing an ingestible drug/device which detects and reverses opioid overdose.
Celero Systems is a life sciences company that develops an ingestible system to detect and reverse opioid overdose.
Raised $3,000,000.00 from PharmStars.
Consultant, Neuroscience Innovation
2021 - 2024
• Evaluate technologies and manage projects that transform the treatment of neurological diseases including neuromuscular, precision psychiatry, and drug delivery. • Developed best practices recommendations for corporate innovation.
Genentech specializes in genetic testing and personalized medicine.
Chairman
2019 - 2024
• Next generation intravascular cardiology imaging combining DeepOCT™ imaging, near infrared spectroscopy (NIRS), and AI-powered insights to optimize coronary stenting and better inform care.
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Raised $79,597,066.00 from Deerfield Management, Nova Ventures, Johnson & Johnson Innovation – JJDC, Heartwork Capital, S3 Ventures, SV Health Investors and Lumira Ventures.
Education
Investments
Latest Articles
•
Why Innovation Heroes are a Sign of a Dysfunctional Organization
Talks about Innovation, Disruptive Innovation and Corporate Innovation
•
The Class That Changed The Way Entrepreneurship Is Taught
Talks about Teaching, Higher Education and Lean Startup
•
Lean LaunchPad — For Deep Science and Technology
Talks about Technology, Lean Startup and Teaching